Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21935,787,0.97 [0.77-1.21],0.7612950228658713
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21926,125,1.26 [0.71-2.24],0.4266648428696766
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23336,135,0.78 [0.46-1.31],0.3448807899188684
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17365,440,1.25 [0.91-1.70],0.1714470446272439
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23282,81,0.61 [0.31-1.19],0.1503761799784929
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22632,69,1.44 [0.67-3.09],0.3546998859306202
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24170,80,0.64 [0.33-1.26],0.1944271061231525
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24190,54,0.92 [0.39-2.14],0.8471763015005693
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22155,40,1.23 [0.45-3.36],0.6926370256360745
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23728,95,1.16 [0.61-2.22],0.6510244991839442
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23692,59,1.38 [0.60-3.16],0.4447830350486986
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24231,58,1.01 [0.44-2.29],0.9840666239960482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24190,90,0.96 [0.50-1.84],0.9033561590766732
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24182,82,1.01 [0.51-2.01],0.9721360265621024
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Mycoses,24020,43,0.74 [0.29-1.86],0.5235352969468323
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23452,336,1.07 [0.76-1.51],0.6917500720252472
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23239,123,1.29 [0.73-2.28],0.3840440537406927
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23334,218,1.14 [0.74-1.75],0.5508111982816326
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20990,28,2.15 [0.65-7.06],0.2068120164600412
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21004,42,0.53 [0.21-1.32],0.1743708801452148
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21075,113,1.02 [0.57-1.85],0.941040659251292
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21080,118,1.08 [0.60-1.92],0.803470505955249
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11785,263,3.22 [2.19-4.74],2.599933135370383e-09
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9462,22,0.39 [0.10-1.46],0.1632543929679104
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21005,43,0.43 [0.18-1.03],0.0573141711599682
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22378,717,1.14 [0.90-1.45],0.2709364026686401
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23318,182,0.88 [0.55-1.40],0.5822375150932482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23866,72,0.68 [0.33-1.39],0.286901633793158
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24293,68,1.30 [0.60-2.81],0.5112588264554617
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Rectum,24089,40,0.44 [0.17-1.13],0.0872578355994356
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24296,34,0.77 [0.27-2.21],0.6253164957482162
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Stomach,24333,27,0.78 [0.24-2.57],0.6854693698826824
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm,24067,259,0.81 [0.56-1.20],0.2944100657558417
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24278,104,0.72 [0.40-1.30],0.2787247161859139
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24277,77,1.02 [0.50-2.09],0.946812380856386
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24248,40,0.62 [0.24-1.60],0.3273436241823776
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Haemangioma, any site",24250,40,0.62 [0.24-1.60],0.3272016577032266
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanocytic naevi,24152,212,1.12 [0.73-1.73],0.5984818220199073
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24298,96,1.32 [0.69-2.51],0.3960833795498154
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Other benign neoplasms of skin,24212,161,1.09 [0.67-1.80],0.7212528068684443
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of breast,13416,81,1.11 [0.57-2.18],0.7564088672463468
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Leiomyoma of uterus,13121,612,0.83 [0.65-1.06],0.1429870535830988
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23457,170,1.83 [1.12-2.97],0.0153905804307423
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23357,309,0.97 [0.68-1.38],0.8502066718429768
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23357,309,0.97 [0.68-1.38],0.8502066718429768
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22257,308,1.22 [0.85-1.75],0.2860515583464732
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23897,72,0.83 [0.40-1.70],0.6031367595923424
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24113,90,0.61 [0.32-1.15],0.1244762720996388
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21299,619,1.26 [0.97-1.64],0.0884880994981255
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23215,372,1.33 [0.96-1.86],0.0903032881039173
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22720,90,0.77 [0.40-1.47],0.4242411838215353
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23655,52,1.32 [0.54-3.24],0.5477435412003876
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22708,78,0.82 [0.41-1.65],0.5758141380880335
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22915,285,1.35 [0.91-2.00],0.1362694827760701
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22908,278,1.35 [0.90-2.01],0.1451525527471804
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22621,156,0.98 [0.56-1.74],0.9532933466599414
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22624,153,1.03 [0.58-1.85],0.9091146204533692
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21160,480,1.61 [1.19-2.18],0.0021191001985131
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20743,63,2.36 [1.05-5.31],0.0373132531925873
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,21123,443,1.62 [1.19-2.23],0.0025359622438522
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20720,40,0.42 [0.17-1.04],0.0602140573320508
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20741,61,0.59 [0.28-1.28],0.1831325793412361
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Any mental disorder,21086,678,1.14 [0.89-1.47],0.2922598743817214
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20673,265,1.37 [0.91-2.07],0.1277110392129837
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23955,199,1.79 [1.12-2.85],0.0152740523493347
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24013,145,1.39 [0.81-2.40],0.2345191726340203
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22577,71,2.30 [1.07-4.97],0.033637936075899
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24234,71,2.12 [0.98-4.58],0.0554860391258645
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20479,71,2.29 [1.06-4.95],0.0356095942683929
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Alcohol dependence,22592,86,1.32 [0.65-2.66],0.4412164472935436
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Smoking dependency,22552,64,0.69 [0.32-1.48],0.3388979668974266
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20478,70,1.07 [0.50-2.29],0.854139502018872
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20746,338,1.20 [0.85-1.70],0.3115212824948823
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Depression,22811,295,1.06 [0.73-1.53],0.7637558925326629
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Depression or dysthymia,20621,257,1.04 [0.70-1.54],0.851098854915673
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20536,128,0.83 [0.48-1.44],0.5145885352218613
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Other anxiety disorders,23018,58,0.76 [0.34-1.70],0.50170019391918
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Neurological diseases,21658,1287,0.87 [0.72-1.04],0.1222056951838772
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20172,155,1.13 [0.68-1.87],0.6380390018158482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24144,126,1.25 [0.71-2.19],0.4339638037031734
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23175,434,0.72 [0.53-0.97],0.0319588587693327
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Epilepsy,22886,145,0.49 [0.30-0.80],0.0039955896659573
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Migraine,22831,90,0.81 [0.42-1.54],0.5142714884184658
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24018,80,0.70 [0.36-1.38],0.3056330630975091
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23901,36,1.15 [0.40-3.33],0.7923892657337124
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other sleep disorders,22896,155,1.03 [0.61-1.73],0.9240263614265464
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Sleep apnoea,23792,119,1.04 [0.58-1.89],0.8908780572617053
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23338,540,0.95 [0.72-1.25],0.7076105471986724
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22919,121,0.91 [0.52-1.61],0.7524042344845685
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23088,290,1.03 [0.71-1.50],0.8708702024169958
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24142,78,1.02 [0.50-2.07],0.9557279341810752
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Hemiplegia,24114,50,1.13 [0.46-2.75],0.7866476630841264
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other neurological diseases,23953,109,0.94 [0.52-1.70],0.8280458287165686
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23920,276,1.12 [0.77-1.64],0.5443142215056371
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23793,149,1.07 [0.64-1.79],0.7916849773902939
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23722,78,1.10 [0.54-2.22],0.7908255716769608
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23732,88,1.01 [0.52-1.96],0.9773436950382604
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23687,43,0.72 [0.29-1.82],0.4895846113420821
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22820,55,1.35 [0.56-3.25],0.4990674117650638
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22929,164,1.08 [0.66-1.78],0.7566818981524985
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23789,107,1.19 [0.65-2.19],0.5750120792259159
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24112,18,1.33 [0.30-5.92],0.7095580279909202
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1552,18,1.19 [0.27-5.31],0.8161025007480665
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22578,18,1.34 [0.30-5.95],0.7043185103032069
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24009,43,1.63 [0.62-4.32],0.3243771087811259
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23989,23,2.26 [0.61-8.35],0.2200011621431216
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23913,81,0.60 [0.31-1.17],0.1322234093263648
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23968,92,1.35 [0.69-2.61],0.3776811021535321
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,24219,109,0.84 [0.46-1.52],0.5582377358207751
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23867,83,0.84 [0.43-1.64],0.6049948477108242
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18979,1732,1.15 [0.97-1.36],0.1133634766837343
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24055,38,0.51 [0.20-1.34],0.1737114945590242
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19905,1161,1.14 [0.93-1.40],0.1972635100388658
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypertension,19921,1177,1.14 [0.93-1.39],0.2087417336375353
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18776,32,0.56 [0.19-1.65],0.2958742159984666
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23010,499,1.35 [1.01-1.81],0.0449735281765098
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Angina pectoris,22811,300,1.34 [0.92-1.96],0.1273685949088831
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23700,117,1.61 [0.88-2.95],0.1194867216643005
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23806,223,1.24 [0.80-1.91],0.3303493438991614
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24239,50,1.92 [0.76-4.85],0.1664702540450008
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22650,139,1.12 [0.65-1.93],0.6709260777287869
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22874,373,1.37 [0.97-1.92],0.0708271431237167
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23878,73,1.98 [0.94-4.17],0.0740929709904762
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23880,155,1.51 [0.90-2.53],0.1159305783296119
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23864,59,0.88 [0.39-1.97],0.7554232522464432
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23865,60,0.94 [0.42-2.10],0.8806550318638414
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18800,56,0.61 [0.27-1.37],0.2318840488934272
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22026,39,0.76 [0.28-2.04],0.5832659474039252
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Conduction disorders,22052,65,0.53 [0.25-1.11],0.0917185189510243
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16538,83,2.11 [1.06-4.20],0.0338081579843929
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16625,170,1.09 [0.67-1.78],0.7238018236665895
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other arrhythmias,22022,35,2.48 [0.87-7.08],0.0909169992852749
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22037,50,0.95 [0.39-2.29],0.9040179896480128
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23887,107,0.83 [0.46-1.52],0.5498657831329887
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23857,99,1.13 [0.60-2.14],0.7009756928656257
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23889,77,0.85 [0.42-1.71],0.6414019134609277
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23931,66,1.14 [0.52-2.49],0.7388562212462162
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23669,44,0.81 [0.32-2.08],0.6674889268355199
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23701,76,1.40 [0.67-2.93],0.3689579517607456
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23267,103,1.09 [0.58-2.03],0.7951656247225445
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23250,86,1.16 [0.58-2.30],0.6742297324454054
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24192,83,1.19 [0.60-2.39],0.6174564537014168
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Varicose veins,23546,382,0.98 [0.71-1.35],0.903165807291772
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypotension,23685,43,0.52 [0.21-1.29],0.1602177894978765
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20584,1717,1.00 [0.85-1.17],0.9831706599574448
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24130,119,1.24 [0.70-2.22],0.4615291433112438
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23275,165,0.90 [0.56-1.47],0.6818689457383751
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23251,141,0.97 [0.57-1.64],0.912433960846923
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23778,193,1.02 [0.65-1.60],0.9340172042424674
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23777,192,1.02 [0.64-1.60],0.948223016912347
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23544,577,0.89 [0.69-1.16],0.3909405368477574
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Chronic sinusitis,23057,90,0.71 [0.38-1.35],0.2978109104504797
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Nasal polyp,23062,95,1.74 [0.91-3.36],0.0958337995701073
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23337,370,0.83 [0.60-1.14],0.2517687343971329
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Deviated nasal septum,23162,195,0.83 [0.54-1.29],0.4164191453665071
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13954,44,1.40 [0.52-3.76],0.5012708495588696
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22265,781,1.10 [0.87-1.39],0.410386917447655
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Early onset COPD,23701,93,1.30 [0.65-2.59],0.4561831838002517
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23701,93,1.30 [0.65-2.59],0.4561831838002517
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23701,93,1.30 [0.65-2.59],0.4561831838002517
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22787,705,1.10 [0.86-1.40],0.4411393062872778
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Asthma,18579,705,1.11 [0.87-1.42],0.3820556037080108
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18446,705,1.12 [0.87-1.42],0.3786241008677689
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18566,692,1.10 [0.86-1.41],0.4286471353928474
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24161,55,0.98 [0.42-2.28],0.9648235435365892
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Interstitial lung disease,23141,43,1.04 [0.40-2.72],0.9408633721272306
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",24219,43,1.04 [0.40-2.71],0.9413693332362556
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23135,37,1.31 [0.46-3.77],0.6139543178965312
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pleural effusion,23139,69,0.92 [0.43-1.94],0.8190223858296215
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other diseases of pleura,23233,163,1.48 [0.90-2.44],0.1259703611817452
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23580,75,2.65 [1.29-5.45],0.0078690214431636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,17258,4535,1.07 [0.96-1.19],0.2532361473110742
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23803,430,0.91 [0.67-1.23],0.5291636167778572
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24269,118,1.05 [0.59-1.86],0.8649419115515925
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Impacted teeth,24274,109,1.05 [0.58-1.89],0.8831142671714597
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Dental caries,23481,108,2.17 [1.17-4.01],0.0138715725667128
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23467,94,0.88 [0.46-1.66],0.6907325269743112
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24257,134,0.92 [0.54-1.57],0.7615781882220103
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23451,78,0.43 [0.22-0.82],0.0107089928908555
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23234,54,0.52 [0.23-1.17],0.1157581689484884
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24223,39,0.43 [0.17-1.09],0.0747018599129787
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19552,185,1.13 [0.71-1.80],0.6162607333893053
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20916,1549,1.16 [0.98-1.38],0.0751896675673232
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oesophagitis,19602,235,1.50 [0.99-2.28],0.0556330690630891
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19862,495,1.21 [0.91-1.62],0.1939316966870208
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19427,60,0.71 [0.32-1.57],0.402787792200008
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19494,127,1.22 [0.69-2.14],0.4918875007891078
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19394,27,1.69 [0.50-5.71],0.4002464099087552
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastric ulcer,19459,92,1.91 [0.99-3.69],0.0525131975434832
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Duodenal ulcer,19462,95,0.81 [0.43-1.54],0.525635721693281
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24241,67,1.06 [0.49-2.29],0.8830519921380565
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Chronic gastritis,19463,96,0.81 [0.43-1.52],0.5032468869683075
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19931,564,1.21 [0.92-1.58],0.1716742148489
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of appendix,24170,144,0.62 [0.37-1.01],0.0556734273180049
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Functional dyspepsia,19706,339,1.33 [0.94-1.88],0.1055728145092562
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19466,99,0.72 [0.39-1.33],0.293886879520697
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24158,173,0.86 [0.54-1.37],0.5224377879676247
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute appendicitis,24139,113,0.65 [0.37-1.15],0.1409421633698708
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Hernia,21921,1048,1.19 [0.97-1.45],0.0919056575092933
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Inguinal hernia,21225,352,1.00 [0.71-1.39],0.980797348859536
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Umbilical hernia,20974,101,1.39 [0.73-2.63],0.3136042347443415
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ventral hernia,20952,79,1.09 [0.54-2.22],0.8034792947866526
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21416,543,1.36 [1.03-1.80],0.0289774326477335
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23560,660,1.02 [0.80-1.31],0.8665708251335653
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of intestines,20025,1469,1.05 [0.88-1.24],0.5898669095257218
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24043,66,0.89 [0.42-1.89],0.7642599721823482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24260,93,1.51 [0.78-2.90],0.2198613692951808
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Crohn disease,22993,93,1.51 [0.78-2.90],0.2196700040770456
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22972,72,2.18 [1.04-4.57],0.0391774862559307
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24210,111,1.44 [0.79-2.63],0.2334241666152919
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ulcerative colitis,23011,111,1.45 [0.79-2.64],0.2290422606980916
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22994,94,1.63 [0.84-3.13],0.14569243788907
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23430,530,0.95 [0.72-1.25],0.7210880582848131
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23426,526,0.96 [0.73-1.26],0.7695859891246286
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18617,61,2.33 [1.04-5.22],0.0401453291603799
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Intestinal stricture,24031,61,2.31 [1.02-5.22],0.0437046474412909
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18601,45,3.14 [1.29-7.61],0.0113390983544627
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18830,274,1.49 [1.01-2.21],0.0458811784371477
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18707,151,0.91 [0.55-1.50],0.7078509497484853
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18773,217,1.17 [0.76-1.80],0.467009103638375
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Constipation,23320,192,0.98 [0.63-1.54],0.9457013479837816
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23953,77,0.85 [0.42-1.70],0.6384748601335973
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18717,161,0.78 [0.48-1.27],0.3228604171020168
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18640,84,0.94 [0.48-1.87],0.8691244569512464
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19260,704,0.96 [0.76-1.22],0.7533381170018892
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of intestine,18715,159,0.73 [0.45-1.19],0.2111751348398256
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23941,65,0.75 [0.35-1.60],0.4598563715793397
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of liver,23682,110,0.83 [0.46-1.49],0.5245065388345437
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of liver,23634,62,1.53 [0.68-3.45],0.3066238505243858
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23204,458,1.38 [1.02-1.86],0.0391695372370897
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Cholelithiasis,23110,364,1.46 [1.04-2.06],0.0289608795335538
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Cholecystitis,22813,67,1.40 [0.64-3.07],0.395964336661276
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22784,38,1.34 [0.48-3.72],0.5724195199182469
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute pancreatitis,22796,50,1.09 [0.44-2.66],0.8563495876089162
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),24170,50,1.07 [0.44-2.63],0.8754615440120208
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23224,256,1.13 [0.76-1.68],0.5389891479032471
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23030,62,0.76 [0.35-1.65],0.4858583876905948
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Coeliac disease,23018,50,0.80 [0.34-1.89],0.6090230041975642
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23007,39,3.78 [1.59-9.01],0.0027040444592742
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23128,160,0.99 [0.60-1.62],0.9713253349465985
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,GI-bleeding,23123,155,0.99 [0.60-1.63],0.9671355126403696
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22057,1309,1.09 [0.91-1.31],0.3435636908561922
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23989,88,1.03 [0.53-2.00],0.9370739987739136
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23967,418,1.15 [0.84-1.56],0.3862292970714542
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23345,460,1.03 [0.77-1.38],0.8588831168277198
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23635,358,1.33 [0.95-1.87],0.1005335101680152
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23372,95,1.39 [0.72-2.68],0.3297867397171549
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23480,203,1.36 [0.86-2.13],0.1850717371521263
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24108,75,0.77 [0.38-1.56],0.4646194813970702
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24096,63,0.64 [0.30-1.37],0.2459127925686269
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24079,46,0.69 [0.28-1.68],0.4110445993961131
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24188,28,3.96 [1.41-11.09],0.0089227513060215
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24185,25,4.51 [1.62-12.55],0.0038886729645999
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23607,58,1.16 [0.51-2.67],0.7227977236153356
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23864,315,1.15 [0.81-1.64],0.4403582555714364
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22946,61,0.77 [0.35-1.69],0.5131633299006861
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22969,84,0.96 [0.49-1.89],0.9037206174495204
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22955,70,0.89 [0.43-1.87],0.7636064999428487
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23063,178,1.21 [0.75-1.94],0.4416408746609825
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23041,156,1.14 [0.69-1.88],0.6205189817347581
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18798,3088,0.86 [0.76-0.98],0.0195236485964353
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,20214,1649,0.81 [0.69-0.95],0.0105899985221591
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22170,963,1.03 [0.84-1.27],0.7616332961142703
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18678,113,0.51 [0.29-0.90],0.0207711839522364
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18877,312,0.72 [0.51-1.04],0.0775223057076179
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24036,108,0.52 [0.30-0.93],0.0272692776533775
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24045,96,0.47 [0.26-0.86],0.0146902183695323
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,19149,584,0.88 [0.67-1.15],0.355027537370479
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",21416,584,0.89 [0.68-1.17],0.4096081284642097
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18606,41,0.79 [0.29-2.12],0.633356240241445
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24001,40,0.76 [0.29-2.03],0.5871651427416874
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18698,133,0.79 [0.45-1.37],0.4000665106408355
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18587,22,1.20 [0.30-4.80],0.7950712551479615
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18680,115,0.85 [0.47-1.54],0.5961757351113139
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24226,59,1.38 [0.60-3.19],0.452158719651181
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18855,290,0.88 [0.60-1.29],0.5139447981775573
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18760,195,0.82 [0.51-1.30],0.3929267281549029
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19651,1086,0.89 [0.73-1.08],0.2410230084647537
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18601,36,1.00 [0.35-2.88],0.9993829273220683
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18720,155,0.69 [0.42-1.13],0.1367548220117771
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18588,23,2.21 [0.56-8.69],0.256653983830987
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18591,26,0.58 [0.17-1.95],0.3806379897409185
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19018,453,0.77 [0.57-1.03],0.0828188695636708
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18944,379,0.74 [0.54-1.03],0.0710493802949268
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19176,245,0.97 [0.65-1.46],0.8939149614101574
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23967,145,0.61 [0.37-1.00],0.0490838488743714
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23859,37,0.52 [0.20-1.36],0.1814928576319697
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21696,45,1.24 [0.48-3.23],0.6523088594967663
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21851,200,1.02 [0.65-1.60],0.9249519776531095
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22456,805,0.96 [0.77-1.20],0.7119091303585454
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21775,124,1.07 [0.60-1.90],0.8199393387906615
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21700,49,1.22 [0.49-3.03],0.6712816064535571
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22327,676,0.95 [0.74-1.21],0.6595026471998051
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21701,50,0.56 [0.46-0.69],4.8160625034903984e-08
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21880,229,0.86 [0.57-1.30],0.4702940771255036
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21752,101,0.84 [0.45-1.55],0.5774067131841875
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21709,58,0.81 [0.36-1.81],0.6027304708927967
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21775,124,0.67 [0.39-1.16],0.150287689808852
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21711,60,0.59 [0.27-1.28],0.1786850629079127
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21938,287,1.03 [0.71-1.50],0.873757153687246
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21457,250,0.77 [0.52-1.14],0.1868647829852165
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21256,49,0.77 [0.32-1.86],0.560042653776742
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21251,44,0.62 [0.25-1.55],0.3067342952620389
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21310,103,0.94 [0.51-1.74],0.8426047067868678
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21256,49,2.43 [0.98-6.05],0.05546764862819
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21261,54,1.85 [0.78-4.40],0.1615781274656544
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21247,40,2.75 [1.05-7.16],0.038975961167379
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21397,190,0.78 [0.50-1.22],0.2708563718385426
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21253,46,1.08 [0.42-2.73],0.8777568712363601
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21252,45,1.02 [0.40-2.62],0.9656512803669834
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21300,93,0.80 [0.42-1.52],0.4938045572256034
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21273,66,1.63 [0.74-3.57],0.2221649667240792
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21590,383,1.07 [0.77-1.48],0.6760770200023019
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21342,135,1.13 [0.66-1.95],0.6573315001598956
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21407,200,1.01 [0.65-1.58],0.9517637487858704
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23090,90,0.65 [0.34-1.23],0.1866862702515073
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23297,297,1.23 [0.85-1.78],0.2722194302196314
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23050,50,1.34 [0.55-3.30],0.5222549314406704
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23057,57,1.26 [0.54-2.92],0.593895400283549
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23102,102,1.50 [0.80-2.84],0.2065072413578248
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20590,3845,0.86 [0.77-0.96],0.0093845150567729
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9870,357,0.89 [0.63-1.27],0.5198259521391594
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23008,162,1.26 [0.77-2.07],0.3632754027699831
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22892,46,1.76 [0.68-4.51],0.2424665461994232
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23152,31,1.05 [0.34-3.27],0.9287501591173672
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23151,30,3.17 [1.11-9.01],0.0308058291052956
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23161,40,0.43 [0.17-1.06],0.0666467057925482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24013,207,1.18 [0.76-1.83],0.4675810926355774
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24073,48,0.70 [0.29-1.70],0.4302365540981413
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23948,142,1.29 [0.76-2.20],0.3482036006648408
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23891,85,1.42 [0.71-2.83],0.3230373350944653
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22989,778,0.86 [0.69-1.08],0.1937185086830468
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Cystitis,22281,70,0.32 [0.16-0.63],0.0010419772778459
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22269,58,0.73 [0.32-1.63],0.4374379496509999
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22369,158,0.66 [0.41-1.07],0.0930774101010193
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22292,81,0.58 [0.30-1.12],0.1059792360092793
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22759,548,1.01 [0.77-1.33],0.918322226215332
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9576,63,0.63 [0.28-1.41],0.2600032324507572
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9546,33,0.59 [0.19-1.79],0.3493907594124358
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Hydrocele,9548,35,3.36 [1.06-10.66],0.0393925323833515
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9586,73,0.80 [0.37-1.72],0.5644388176460853
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9571,58,1.00 [0.42-2.38],0.9988471427253948
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9598,85,1.00 [0.49-2.04],0.9952561473756466
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13291,221,1.18 [0.78-1.77],0.4373129701039402
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13137,67,0.85 [0.41-1.76],0.6640747795718944
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,13144,74,1.40 [0.69-2.84],0.3549422169828816
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13118,48,0.72 [0.31-1.66],0.4374928539975593
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13259,338,0.80 [0.58-1.11],0.1763060165745228
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12992,71,0.71 [0.35-1.42],0.3297528803266291
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13093,172,0.76 [0.48-1.18],0.219680018041925
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,12233,2417,0.92 [0.80-1.05],0.2314569354433152
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Endometriosis,10071,255,0.74 [0.51-1.07],0.1075758141118959
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9897,81,0.82 [0.42-1.58],0.5516387357405828
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9917,101,1.02 [0.56-1.86],0.9549769827739848
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10086,270,0.85 [0.59-1.23],0.3944910717617126
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10083,267,0.61 [0.43-0.88],0.0080472948872275
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10239,423,0.93 [0.69-1.26],0.6582557975866532
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9962,146,0.96 [0.58-1.58],0.8686127805595751
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10007,191,1.13 [0.72-1.76],0.5899050846561817
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9889,73,0.54 [0.28-1.05],0.0701733994070409
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9940,124,0.89 [0.52-1.52],0.6638455953987967
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13422,174,1.09 [0.69-1.72],0.7163366666878286
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13431,168,1.06 [0.67-1.69],0.807314233127042
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13447,97,1.04 [0.57-1.91],0.8923908100391592
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13439,104,1.07 [0.60-1.93],0.8154475805704976
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9875,59,1.92 [0.87-4.25],0.1072982651503855
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9869,53,1.02 [0.44-2.34],0.969464865269272
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9877,61,0.30 [0.15-0.61],0.0006931484571636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Irregular menses,13362,324,0.86 [0.61-1.19],0.3612345373043052
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10817,1001,0.96 [0.79-1.17],0.7005595428504042
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10503,687,1.03 [0.81-1.31],0.8127574248343453
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13434,138,1.18 [0.71-1.99],0.5216907928756828
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,10123,307,0.88 [0.63-1.25],0.4837752528919919
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,10049,233,0.95 [0.64-1.41],0.7891710762808086
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10044,228,1.34 [0.88-2.05],0.1700528253821901
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Female infertility,9901,85,0.62 [0.33-1.15],0.1293037533861082
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9894,78,0.72 [0.37-1.39],0.3211533061452511
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13440,726,1.07 [0.84-1.36],0.5850028261867636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13449,1004,1.06 [0.86-1.31],0.5738890456176506
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13441,387,0.95 [0.70-1.29],0.732869223320335
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,13164,110,1.51 [0.85-2.70],0.1599851119230321
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,13207,153,1.07 [0.66-1.73],0.7915493757617782
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,13191,137,0.71 [0.43-1.17],0.1752994487381516
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13457,138,0.91 [0.55-1.50],0.7115878547328063
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13459,136,0.94 [0.57-1.56],0.8127270419557163
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13456,357,1.19 [0.86-1.65],0.2884290320558247
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,13206,107,1.64 [0.91-2.97],0.0999194730042834
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13296,197,0.98 [0.64-1.49],0.9122100042992174
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12837,123,1.09 [0.64-1.85],0.7610778960305087
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12886,172,0.90 [0.57-1.41],0.6454965938588062
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12912,198,1.20 [0.78-1.85],0.4067958820974623
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12838,124,0.92 [0.54-1.56],0.74501729578201
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12828,114,1.37 [0.77-2.41],0.281232779163172
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12841,127,1.24 [0.73-2.12],0.427619667354136
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12631,186,1.14 [0.73-1.75],0.5674884545243721
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12814,369,1.12 [0.81-1.55],0.4759448222196984
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,13003,558,1.14 [0.86-1.49],0.3620891002641995
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13462,147,1.16 [0.71-1.89],0.566177255821678
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,12245,112,1.19 [0.68-2.10],0.5443323997822334
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12529,84,0.86 [0.46-1.61],0.6431364361405771
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13467,286,0.85 [0.60-1.21],0.378281924991027
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13404,223,0.92 [0.62-1.37],0.6822149048608006
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13456,212,1.01 [0.67-1.52],0.9776053129093694
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13447,203,0.96 [0.63-1.45],0.8293440331990447
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24114,32,0.68 [0.23-1.98],0.4777582041752902
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22869,449,1.01 [0.75-1.36],0.9602355439860888
